Analgesic use before and after oral anticoagulant initiation-a population-based study in Finland




Ilomaki J, Helin-Salmivaara A, Huupponen R, Rikala M, Kirkpatrick CM, Korhonen MJ

PublisherSPRINGER HEIDELBERG

2015

European Journal of Clinical Pharmacology

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

EUR J CLIN PHARMACOL

71

6

723

732

10

0031-6970

DOIhttps://doi.org/10.1007/s00228-015-1836-9



The use of NSAIDs decreases extensively among warfarin initiators which is encouraging. However, the use of NSAIDs increases among rivaroxaban and dabigatran initiators. This is a concern as the bleeding risk may increase due to potential pharmacodynamic interactions.




Last updated on 2024-26-11 at 18:52